A Nobel Prize Winner’s Startup Raised $350 Million. Now It Can’t Fund Its Cancer Programs

By admin

Oct 8, 2026 • 1 min read

Editorial 16:9 cinematic photography illustrating A Nobel Prize Winner’s Startup Raised $350 Million. Now It Can’t Fund Its Cancer Programs in mod

The Berkeley gene-editing company will wind down its lymphoma and myeloma studies and explore a potential sale.

Was this article helpful?